NGoggle’s goal is to promote neurodiagnostics and treatment with non-invasive BCI. We envision wearable BCI systems to monitor and expedite the diagnosis and treatment of neurodegenerative diseases.
The Company’s aim is to license its NeuroDX platform – an embedded EEG Virtual Reality (VR) head mount device for neuro-stimulation and feedback.
Based in San Diego, NGoggle is “consumerizing” BCI one obstacle at at time: it holds several patents in the miniaturization of sensors, software noise / artifact removal techniques, and machine/deep learning algorithms for detecting and tracking ophthalmic disease progression.
